chr1-109751321-C-T

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_133181.4(EPS8L3):​c.1594G>A​(p.Glu532Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00132 in 1,613,918 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0010 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 5 hom. )

Consequence

EPS8L3
NM_133181.4 missense

Scores

1
2
15

Clinical Significance

Likely benign criteria provided, single submitter B:2

Conservation

PhyloP100: 1.99

Publications

4 publications found
Variant links:
Genes affected
EPS8L3 (HGNC:21297): (EPS8 signaling adaptor L3) This gene encodes a protein that is related to epidermal growth factor receptor pathway substrate 8 (EPS8), a substrate for the epidermal growth factor receptor. The function of this protein is unknown. Alternatively spliced transcript variants encoding different isoforms exist. [provided by RefSeq, Jul 2008]
GSTM5 (HGNC:4637): (glutathione S-transferase mu 5) Cytosolic and membrane-bound forms of glutathione S-transferase are encoded by two distinct supergene families. At present, eight distinct classes of the soluble cytoplasmic mammalian glutathione S-transferases have been identified: alpha, kappa, mu, omega, pi, sigma, theta and zeta. This gene encodes a glutathione S-transferase that belongs to the mu class. The mu class of enzymes functions in the detoxification of electrophilic compounds, including carcinogens, therapeutic drugs, environmental toxins and products of oxidative stress, by conjugation with glutathione. The genes encoding the mu class of enzymes are organized in a gene cluster on chromosome 1p13.3 and are known to be highly polymorphic. These genetic variations can change an individual's susceptibility to carcinogens and toxins as well as affect the toxicity and efficacy of certain drugs. Diversification of these genes has occurred in regions encoding substrate-binding domains, as well as in tissue expression patterns, to accommodate an increasing number of foreign compounds. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.016572148).
BP6
Variant 1-109751321-C-T is Benign according to our data. Variant chr1-109751321-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 3045009.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 157 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_133181.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EPS8L3
NM_133181.4
MANE Select
c.1594G>Ap.Glu532Lys
missense
Exon 17 of 19NP_573444.2
EPS8L3
NM_139053.3
c.1597G>Ap.Glu533Lys
missense
Exon 17 of 19NP_620641.1Q8TE67-3
EPS8L3
NM_024526.4
c.1504G>Ap.Glu502Lys
missense
Exon 17 of 19NP_078802.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EPS8L3
ENST00000361965.9
TSL:1 MANE Select
c.1594G>Ap.Glu532Lys
missense
Exon 17 of 19ENSP00000355255.4Q8TE67-1
EPS8L3
ENST00000369805.7
TSL:1
c.1597G>Ap.Glu533Lys
missense
Exon 17 of 19ENSP00000358820.3Q8TE67-3
EPS8L3
ENST00000361852.8
TSL:1
c.1504G>Ap.Glu502Lys
missense
Exon 17 of 19ENSP00000354551.4Q8TE67-2

Frequencies

GnomAD3 genomes
AF:
0.00103
AC:
157
AN:
152160
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00190
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00153
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00132
AC:
332
AN:
251034
AF XY:
0.00129
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.00185
Gnomad ASJ exome
AF:
0.0000994
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000930
Gnomad NFE exome
AF:
0.00188
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
AF:
0.00135
AC:
1971
AN:
1461640
Hom.:
5
Cov.:
31
AF XY:
0.00134
AC XY:
975
AN XY:
727092
show subpopulations
African (AFR)
AF:
0.000299
AC:
10
AN:
33480
American (AMR)
AF:
0.00179
AC:
80
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00153
AC:
132
AN:
86212
European-Finnish (FIN)
AF:
0.000282
AC:
15
AN:
53280
Middle Eastern (MID)
AF:
0.000693
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
0.00148
AC:
1651
AN:
1111968
Other (OTH)
AF:
0.00129
AC:
78
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
95
190
285
380
475
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00103
AC:
157
AN:
152278
Hom.:
0
Cov.:
32
AF XY:
0.00103
AC XY:
77
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.000385
AC:
16
AN:
41552
American (AMR)
AF:
0.00190
AC:
29
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10616
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00153
AC:
104
AN:
68016
Other (OTH)
AF:
0.00237
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00141
Hom.:
3
Bravo
AF:
0.00105
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.000930
AC:
8
ExAC
AF:
0.00143
AC:
173
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00120
EpiControl
AF:
0.00166

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
EPS8L3-related disorder (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.028
T
Eigen
Benign
-0.022
Eigen_PC
Benign
-0.10
FATHMM_MKL
Benign
0.40
N
LIST_S2
Benign
0.81
T
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.017
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Pathogenic
3.1
M
PhyloP100
2.0
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-2.3
N
REVEL
Benign
0.16
Sift
Uncertain
0.014
D
Sift4G
Benign
0.17
T
Polyphen
0.65
P
Vest4
0.38
MVP
0.47
MPC
0.38
ClinPred
0.055
T
GERP RS
2.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.22
gMVP
0.38
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76425431; hg19: chr1-110293943; API